Cargando…

Hand grip strength and risk of incident venous thromboembolism: The Tromsø study

BACKGROUND: Hand grip strength (HGS), a common proxy of whole‐body muscular strength, is associated with a wide range of adverse health outcomes and mortality. However, there are limited data on the association between HGS and risk of venous thromboembolism (VTE). OBJECTIVES: We aimed to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leknessund, Oda G. R., Morelli, Vania M., Strand, Bjørn Heine, Hansen, John‐Bjarne, Brækkan, Sigrid K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634490/ https://www.ncbi.nlm.nih.gov/pubmed/36349264 http://dx.doi.org/10.1002/rth2.12833

Ejemplares similares

Hand grip strength in venous thromboembolism: risk of recurrence and mortality
por: Leknessund, Oda G.R., et al.
Publicado: (2023)

Impact of respiratory symptoms and oxygen saturation on the risk of incident venous thromboembolism—the Tromsø study
por: Børvik, Trond, et al.
Publicado: (2020)

Weight Change and Risk of Venous Thromboembolism: The Tromsø Study
por: Horvei, Lars Daae, et al.
Publicado: (2016)

Joint effect of myocardial infarction and obesity on the risk of venous thromboembolism: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2022)

Role of microRNAs in Venous Thromboembolism
por: Morelli, Vânia M., et al.
Publicado: (2020)

Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2014)

Surgery As a Trigger for Incident Venous Thromboembolism: Results from a Population-Based Case-Crossover Study
por: Meknas, Dana, et al.
Publicado: (2023)

Platelet Count Measured Prior to Cancer Development Is a Risk Factor for Future Symptomatic Venous Thromboembolism: The Tromsø Study
por: Jensvoll, Hilde, et al.
Publicado: (2014)

White Blood Cell Count Measured Prior to Cancer Development Is Associated with Future Risk of Venous Thromboembolism – The Tromsø Study
por: Blix, Kristine, et al.
Publicado: (2013)

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study
por: Rinde, Ludvig B., et al.
Publicado: (2016)

Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study
por: Sejrup, Joakim K., et al.
Publicado: (2020)

Atrial fibrillation, venous thromboembolism, ischemic stroke, and all‐cause mortality: The Tromsø study
por: Hald, Erin Mathiesen, et al.
Publicado: (2020)

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study
por: Lind, Caroline, et al.
Publicado: (2017)

Risk factors and predictors for venous thromboembolism in people with ischemic stroke: A systematic review
por: Tøndel, Birgitte G., et al.
Publicado: (2022)

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022)

Reference values for Jamar+ digital dynamometer hand grip strength in healthy adults and in adults with non-communicable diseases or osteoarthritis: the Norwegian Tromsø study 2015–2016
por: Svinøy, Odd-Einar, et al.
Publicado: (2023)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study
por: Morelli, Vânia M., et al.
Publicado: (2019)

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study
por: Småbrekke, Birgit, et al.
Publicado: (2016)

Red Cell Distribution Width and Risk of Atrial Fibrillation and Subsequent Thromboembolism: The Tromsø Study
por: Hald, Erin M., et al.
Publicado: (2020)

The association of grip strength from midlife onwards with all-cause and cause-specific mortality over 17 years of follow-up in the Tromsø Study
por: Strand, Bjørn Heine, et al.
Publicado: (2016)

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study
por: Johnsen, Stein Harald, et al.
Publicado: (2018)

Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study
por: Grimnes, Gro, et al.
Publicado: (2017)

Risk of a permanent work-related disability pension after incident venous thromboembolism in Denmark: A population-based cohort study
por: Jørgensen, Helle, et al.
Publicado: (2021)

Serum osteoprotegerin and renal function in the general population: the Tromsø Study
por: Vik, Anders, et al.
Publicado: (2017)

The Interaction Between Venous Thromboembolism and Socioeconomic Status on the Risk of Disability Pension
por: Jørgensen, Helle, et al.
Publicado: (2022)

Plasma procoagulant phospholipid clotting time and venous thromboembolism risk
por: Ramberg, Cathrine, et al.
Publicado: (2021)

Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
por: Skjelbakken, Tove, et al.
Publicado: (2014)

Do More Recent Born Generations of Older Adults Have Stronger Grip? A Comparison of Three Cohorts of 66- to 84-Year-Olds in the Tromsø Study
por: Strand, Bjørn Heine, et al.
Publicado: (2019)

Dietary intake of marine n‐3 polyunsaturated fatty acids and future risk of venous thromboembolism
por: Isaksen, Trond, et al.
Publicado: (2018)

Long-Term Incidence of Venous Thromboembolism in Cancer: The Scandinavian Thrombosis and Cancer Cohort
por: Gade, Inger Lise, et al.
Publicado: (2018)

Norwegian reference values for the Short Physical Performance Battery (SPPB): the Tromsø Study
por: Bergland, Astrid, et al.
Publicado: (2019)

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer
por: Ellingsen, Trygve S., et al.
Publicado: (2018)

C-reactive protein and risk of venous thromboembolism: results from a population-based case-crossover study
por: Grimnes, Gro, et al.
Publicado: (2018)

Estimated lifetime risk of venous thromboembolism in men and women in a Danish nationwide cohort: impact of competing risk of death
por: Arnesen, Carl Arne Løchen, et al.
Publicado: (2021)

Differences in sarcopenia prevalence between upper-body and lower-body based EWGSOP2 muscle strength criteria: the Tromsø study 2015–2016
por: Johansson, Jonas, et al.
Publicado: (2020)

Comparing associations of handgrip strength and chair stand performance with all-cause mortality—implications for defining probable sarcopenia: the Tromsø Study 2015–2020
por: Johansson, Jonas, et al.
Publicado: (2023)

Fibrinogen gamma gene rs2066865 and risk of cancer-related venous thromboembolism
por: Paulsen, Benedikte, et al.
Publicado: (2020)

Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study
por: Solomon, Terry, et al.
Publicado: (2016)

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study
por: Lappegård, Jostein, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vij5s9u9jdc45ln19f12v294rc